HomeNDC LookupRxCUI directory › RxCUI 1010878

Lidocaine hydrochloride 40 MG/ML Mucous Membrane Topical Solution — RxCUI 1010878

RxNorm drug concept · Semantic clinical drug
RxCUI 1010878 Semantic clinical drug · SCD ● Current RxNorm concept 16 FDA products 16 package NDCs Snapshot Jul 14, 2026

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1010878
Official nameLidocaine hydrochloride 40 MG/ML Mucous Membrane Topical Solution
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known aslidocaine hydrochloride 4 % Oromucosal Solution; lidocaine HCl 4 % Mucous Membrane Topical Solution; lidocaine hydrochloride 4 % Mucous Membrane Topical Solution
FDA products mapped16
Package NDCs mapped16
Reported Medicaid activity (SDUD)5,839 prescriptions · 25 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Lidocaine Transdermal Patch: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • This patch is used to treat post-herpetic neuralgia — that's the persistent burning or aching nerve pain that sometimes sticks around after a shingles outbreak, even after the rash...
  • What is this patch actually for — why did my doctor prescribe it?
  • You wear it for up to 12 hours, then take it off for the next 12 hours — think of it as '12 hours on, 12 hours off.' Your prescriber may allow up to 3 patches at a time, but never...
  • How long do I wear the patch, and can I wear more than one?
📖 Read our full Lidocaine Transdermal Patch guide →

🕸️ Concept Web — How Lidocaine hydrochloride 40 MG/ML Mucous Membrane... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Lidocaine hydrochloride 40 MG/ML Mucous Membrane Topical Solution RxCUI 1010878

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 2

    The active substance itself — no strength, form, or brand attached yet.

    • Lidocaine 6387
    • Lidocaine hydrochloride 142440
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Xylocaine 202398
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Lidocaine Mucous Membrane Topical Solution 375137
    • Lidocaine hydrochloride Mucous Membrane Topical Solution 2645381
    • Lidocaine Mucosal Product 1164660
    • Lidocaine hydrochloride Mucosal Product 2659393
    • Lidocaine Mucous Membrane Topical Solution [Xylocaine] 543931
    • Lidocaine hydrochloride Mucous Membrane Topical Solution [Xylocaine] 2656307
    • Xylocaine Mucosal Product 1186621
    • Mucous Membrane Topical Solution 316956
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Lidocaine hydrochloride 40 MG/ML 1010843
    • Lidocaine hydrochloride 40 MG/ML Mucous Membrane Topical Solution [Xylocaine] 1246113
    • Lidocaine hydrochloride 40 MG/ML [Xylocaine] 1010845

Showing up to 8 concepts per family — 14 of 15 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Lidocaine hydrochloride 40 MG/ML SCDC · 1010843
  • Lidocaine Mucous Membrane Topical Solution SCDF · 375137
  • Lidocaine hydrochloride Mucous Membrane Topical Solution SCDFP · 2645381
  • Lidocaine Mucosal Product SCDG · 1164660
  • Lidocaine hydrochloride Mucosal Product SCDGP · 2659393

Brand-Name Concepts

  • Lidocaine hydrochloride 40 MG/ML Mucous Membrane Topical Solution [Xylocaine] SBD · 1246113
  • Lidocaine hydrochloride 40 MG/ML [Xylocaine] SBDC · 1010845
  • Lidocaine Mucous Membrane Topical Solution [Xylocaine] SBDF · 543931
  • Lidocaine hydrochloride Mucous Membrane Topical Solution [Xylocaine] SBDFP · 2656307
  • Xylocaine Mucosal Product SBDG · 1186621
  • Xylocaine BN · 202398

📦 FDA Products & Package NDCs

16 products · 16 package NDCs
16 package NDCs map to RxCUI 1010878 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00054-3505-47 50 mL in 1 BOTTLE (0054-3505-47) Lidocaine Hydrochloride Hikma Pharmaceuticals USA Inc. 1985-04-03
00116-4025-50 1 BOTTLE, GLASS in 1 CARTON (0116-4025-50) / 50 mL in 1 BOT... LIDOCAINE HYDROCHLORIDE Xttrium Laboratories, Inc. 2025-03-31
00121-0972-51 1 BOTTLE, GLASS in 1 CARTON (0121-0972-51) / 50 mL in 1 BOT... Lidocaine Hydrochloride PAI Holdings, LLC dba PAI Pharma 2023-07-31
00527-6004-80 1 BOTTLE in 1 CARTON (0527-6004-80) / 50 mL in 1 BOTTLE Lidocaine Hydrochloride Lannett Company, Inc. 2007-02-27
10135-0736-51 1 BOTTLE in 1 CARTON (10135-736-51) / 50 mL in 1 BOTTLE Lidocaine Hydrochloride Marlex Pharmaceuticals, Inc. 2022-06-01
51407-0825-50 50 mL in 1 BOTTLE (51407-825-50) Lidocaine Hydrochloride Golden State Medical Supply, Inc. 2023-08-08
51662-1553-03 25 POUCH in 1 CASE (51662-1553-3) / 1 VIAL in 1 POUCH (5166... LIDOCAINE HCl HF Acquisition Co LLC, DBA HealthFirst 2021-06-14
51672-1411-03 1 BOTTLE in 1 CARTON (51672-1411-3) / 50 mL in 1 BOTTLE Lidocaine Hydrochloride Sun Pharmaceutical Industries, Inc. 2023-12-08
63629-2096-01 50 mL in 1 BOTTLE (63629-2096-1) Lidocaine Hydrochloride Bryant Ranch Prepack 2021-02-11
63739-0997-64 1 BOTTLE in 1 CARTON (63739-997-64) / 50 mL in 1 BOTTLE Lidocaine Hydrochloride McKesson Corporation dba SKY Packaging 2024-06-27
70954-0518-10 1 BOTTLE in 1 CARTON (70954-518-10) / 50 mL in 1 BOTTLE Lidocaine Hydrochloride Novitium Pharma LLC 2022-03-23
72162-1098-02 1 BOTTLE in 1 CARTON (72162-1098-2) / 50 mL in 1 BOTTLE Lidocaine Hydrochloride Bryant Ranch Prepack 2023-09-26
72162-2620-02 1 BOTTLE, GLASS in 1 CARTON (72162-2620-2) / 50 mL in 1 BOT... LIDOCAINE HYDROCHLORIDE Bryant Ranch Prepack 2026-04-20
72162-2627-02 1 BOTTLE in 1 CARTON (72162-2627-2) / 50 mL in 1 BOTTLE Lidocaine Hydrochloride Bryant Ranch Prepack 2026-04-23
76329-6300-05 25 VIAL in 1 CARTON (76329-6300-5) / 4 mL in 1 VIAL Lidocaine Hydrochloride International Medication Systems, Limited 2012-06-19
83148-0043-50 1 BOTTLE in 1 CARTON (83148-043-50) / 50 mL in 1 BOTTLE Lidocaine Hydrochloride The J. Molner Company LLC 2024-11-01
Observed labelers: Bryant Ranch Prepack (4) · Golden State Medical Supply, Inc. (1) · HF Acquisition Co LLC, DBA HealthFirst (1) · Hikma Pharmaceuticals USA Inc. (1) · International Medication Systems, Limited (1) · Lannett Company, Inc. (1) · +7 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.